H5N1 Milk Detection Study
Emory University · with National Institute of Allergy and Infectious Diseases (NIAID) · NCT06850298
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–64 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- May 9, 2025
- Record last updated
- April 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to determine whether drinking pasteurized milk (milk heated to kill harmful germs) that contains inactive particles of a flu virus called A(H5) could lead to the detection of the virus in the nose or throat. Inactive particles are not capable of causing disease. The results will help the Centers for Disease Control and Prevention (CDC) better understand how milk consumption could affect flu surveillance. Investigators also want to see if the body produces antibodies in response to this milk consumption.
Being studied: Pasteurized milk contaminated with killed A(H5) virus
Conditions: Influenza
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals aged 18-64 years
- BMI ≤ 35 kg/m2
- Able to understand and give informed consent (American English) and comply with study visits and procedures.
- In good general health based on medical history and the investigator's clinical judgment.
Exclusion Criteria
- Symptoms of acute respiratory illness or conjunctivitis within 7 days
- Febrile illness in the previous 72 hours
- Recent influenza antiviral use (within 14 days)
- Immunosuppression due to illness or medications
- Current pregnancy or breastfeeding
- History of allergy or intolerance to milk or milk alternatives
- Consumption of raw (unpasteurized) milk within the previous 14 days
- Recent work (within 14 days) on a farm with animals known to be infected with A(H5) virus
- Previous receipt of A(H5) vaccine at any time
Recruiting US locations
Hope Clinic
Atlanta, GA 30322
Site contact: Daniel Graciaa, MD, MPH, MSc · 404-712-1370 · dsgraci@emory.edu
Study contacts (from the official record)
- Daniel Graciaa, MD, MPH, MSc · 404-712-1370 · dsgraci@emory.edu
Similar studies in Georgia
All healthy volunteers studies in Georgia →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Influenza Human Challenge Model
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A/Texas Flu Challenge
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Atlanta, GA + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Decatur, GA + 49 other US sites
- Eligibility basics
- Ages 60+